key: cord-0955287-u3vpt1gk
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: Correspondence on “Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non‐small‐cell lung cancer patient”
date: 2022-03-07
journal: Thorac Cancer
DOI: 10.1111/1759-7714.14371
sha: 91ac0fae0becd1897f2cb557be50622d3f5b3d8a
doc_id: 955287
cord_uid: u3vpt1gk

nan

We would like to share ideas on the publication "Diabetic ketoacidosis shortly after COVID-19 vaccination in a nonsmall -cell lung cancer patient receiving combination of PD-1 and CTLA-4 inhibitors: A case report. 1 " Makiguchi et al. stated: "We speculate that the immune-related adverse event and immunogenicity of vaccination synergistically induced DKA. 1 " We accept that the COVID-19 vaccination may have side effects. Sasaki et al. presented an intriguing underlying pathomechanism in which the vaccine could cause aberrant immunity and DKA. 2 However, there is a lengthy time between vaccination and the onset of diabetes. We should be aware of the likelihood of a medical issue co-occurring with the COVID-19 vaccine that can lead to type 1 diabetes in a COVID-19 vaccine recipient. A vaccination recipient, for example, could develop dengue, 3 and dengue could be a cause of DKA. 4 Finally, we agree with the conclusions of Sasaki et al. 2 on the importance of a thorough assessment of the problem and the recognition of probable vaccination-induced diabetes. On the other hand, we would like to add a note about another possible concurrent issue that could cause DKA in a vaccine recipient. 

Diabetic ketoacidosis shortly after COVID-19 vaccination in a non-small-cell lung cancer patient receiving combination of PD-1 and CTLA-4 inhibitors: a case report. Thorac Cancer

Newly developed type 1 diabetes after COVID-19 vaccination: a case report

Dengue after COVID-19 vaccination: possible and might be missed

A case report of dengue hemorrhagic fever complicated with diabetic ketoacidosis in a child: challenges in clinical management